Maryland, USA


Located just 10 minutes from Emergent headquarters, our 70,000 sq. ft. Rockville, MD (USA) facility is home to drug product manufacturing for vaccines and therapeutics. The facility has the capabilities to fill, lyophilize, inspect, label, package, and store vaccine products. Our Rockville team has specific knowledge, experience, and capabilities in:

  • Viscous and non-viscous solutions/suspensions
  • Large molecule sterile drug product capabilities
  • Products with stability challenges (such as sensitivity to light or oxygen)
  • Lyophilization development, optimization, and commercialization for both vials and syringes

Drug Product Manufacturing:
Clinical & Commercial GMP

Emergent CDMO clients collaborating with our Rockville team capitalize on our groninger® INTEGRA, a high speed filling line for vaccines and biotherapeutics. With an integrated SKAN isolator, the INTEGRA is ideal for large-scale clinical and commercial fill/finish projects. Within the facility, we offer automated visual inspection and packaging and labeling solutions.

  • Vial size range capability 2R to 100R
    • 2R – Q1 2023 | 10R H1 2023
  • Batch sizes up to 162,000 vials (2R)
  • 14,000 vials/hour (2R) fill rate
  • Manufacturing Ready – Q1 2023 
  • Late-stage clinical or commercial products

Download INTEGRA Facts Sheet


To help streamline their success throughout the cGMP drug product manufacturing process in Rockville, we offer our clients a comprehensive range of support services that include:

  • Raw materials testing
  • Finished product release testing
  • Stability testing
  • Packaging
  • Visual inspection
  • Cold storage

Would you like to visit our Rockville site?

Request A Tour